Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2026-02-03 @ 11:04 PM
Study NCT ID:
NCT02638766
Status:
COMPLETED
Last Update Posted:
2023-03-27
First Post:
2015-11-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
Sponsor:
Grupo Espanol de Investigacion en Sarcomas
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
REGISTRI (GEIS 40)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |